Skip to main content

Table 1 Demographic, epidemiological, clinical, and laboratory features of study patients

From: Clinical and epidemiological predictors of transmission in Severe Acute Respiratory Syndrome (SARS)

Demographics

n

(%)

Age

  

- < = 24

23

23.5%

- 25 to 49

61

62.2%

- 50 and above

14

14.3%

Female gender

79

80.6%

Non-Chinese ethnicity

40

40.8%

Epidemiological features

n

(%)

Context of exposure to SARS

  

- healthcare worker

57

58.2%

- hospital inpatient

10

10.2%

- *others

31

31.6%

Date of onset

  

- 21/3/03 or earlier (before universal PPE)

78

79.6%

- 22/3//03 or later (after universal PPE)

20

20.4%

Delayed isolation (on Day 7 or later)

34

34.7%

Ever admitted to a non-isolation ward

12

12.2%

Ever admitted to a non-isolation ward

12

12.2%

Clinical features

n

(%)

Chronic illness

  

- chronic respiratory illness

7

7.1%

- disease with immunosuppression

10

10.2%

Disease severity at time of isolation

  

- had an abnormal chest radiograph

78

79.6%

- required oxygen therapy

14

14.3%

- admitted to intensive care or high dependency

4

4.1%

- intubated

2

2.0%

Signs and symptoms at time of isolation

  

- temperature > = 38°C

74

75.5%

- fever

95

96.9%

- cough

55

56.1%

- dyspnoea

24

24.5%

- vomiting

17

17.3%

- diarrhoea

14

14.3%

Chest radiograph and confirmatory tests for SARS

  

- ever had abnormal CXR

88

89.8%

- positive PCR specimen

13

13.3%

- positive serology

91

92.9%

^Other laboratory investigations

Median

(IQR)

- highest alanine aminotransferase (7–36 IU/L)

21

(14–41)

- highest lactate dehydrogenase (200–500 IU/L)

447

(348–650)

- lowest platelet count (160-390*10^9/L)

184

(145–220)

- highest neutrophil count (4-10*10^9/L)

3.36

(2.35–5.04)

- lowest lymphocyte count (1.5-4.3*10^9/L)

0.93

(0.66–1.21)

  1. *others: original imported index patient and hospital visitors
  2. ^reference ranges given in brackets